Figure 1:
Comparison of renal function assessment using serum Cystatin C- and serum Creatinine-eGFR among Heart Failure, LVAD and Heart Transplant patients.
p-value: * 0.05–0.001; ** 0.001–0.0001; *** <0.0001; all comparisons denoted with any * had a false discovery rate <0.05. HF, heart failure; HT, heart transplant, LVAD, left ventricular assist device.